Related content

Soluble receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation

By Chen Chun-Hsiung   Chen Hung-An   Liao Hsien-Tzung   Liu Chin-Hsiu   Tsai Chang-Youh   Chou Chung-Tei  

Clinical Rheumatology, Vol. 29, Iss. 10, 2010-10 ,pp. : 1155-1161

Springer Publishing Company

Access to resources Recommend Favorite

Receptor activator of nuclear factor B ligand (RANKL): another link between breast and bone

By Martin T.J.   Gillespie M.T.  

Trends in Endocrinology and Metabolism, Vol. 12, Iss. 1, 2001-01 ,pp. : 2-4

Elsevier

Access to resources Recommend Favorite

Interleukin (IL)-6 and receptor activator of nuclear factor (NF)-κB ligand (RANKL) are increased in the serum of a patient with primary pachydermoperiostosis

By Rendina D.   De Filippo G.   Viceconti R.   Soscia E.   Sirignano C.   Salvatore M.   Della Monica M.   Scarano G.   Mossetti G.  

Scandinavian Journal of Rheumatology, Vol. 37, Iss. 3, 2008-01 ,pp. : 225-229

Informa Healthcare

Access to resources Recommend Favorite

Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells

By Fister Stefanie   Schlotawa Lars   Gunthert Andreas   Emons Gunter   Grundker Carsten  

Gynecological Endocrinology, Vol. 24, Iss. 1, 2007-10 ,pp. : 24-29

Informa Healthcare

Access to resources Recommend Favorite

Evolved regulation of gonadotropin-releasing hormone receptor cell surface expression

By Janovick Jo   Ulloa-Aguirre Alfredo   Conn P.  

Endocrine Journal, Vol. 22, Iss. 3, 2003-12 ,pp. : 317-327

Humana Press, Inc

Access to resources Recommend Favorite